5-fluorouracil-leucovorin with or without carboplatin as adjuvant treatment for primary Dukes B2-C colon cancer; chronomodulated versus standard administration. A multicenter randomized phase III trial of the GRECCR-Belgium (Study 03).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Fluorouracil; Folinic acid
- Indications Colorectal cancer
- Focus Therapeutic Use
- 20 Sep 2013 Biomarkers information updated
- 27 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Aug 2005 New trial record.